ALT-801

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Efficacy and Safety of ALT-801 in the Treatment of ObesityNCT05295875ALTPhase 2Completed2023-09-28Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.